Company intelligence / Profile preview

Richmond Pharmacology

London, England, United Kingdomrichmondpharmacology.com ↗

Ownership: Private
Employees: ~218
Development stage: Commercial

Overview

Richmond Pharmacology Ltd is an active UK-based contract research organization specializing in First-In-Human and early phase clinical trials. The company has conducted over 500 clinical trials, collaborating with international pharmaceutical and biotech organizations to reduce drug development timelines. It holds MHRA Phase I accreditation and operates primarily from its London Bridge site at Guy’s Drug Research Unit.

Therapeutic areas: Other
Modalities: Small moleculesGene editing & silencingBiologics
Industry: Contract Research Organization

Partnerships

International pharmaceutical companiesInternational biotechnology companies

Beyond the preview

Go deeper on Richmond Pharmacology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Richmond Pharmacology.

Explore the full profile